Clinical trial
Efficacy of Transseptal and Transconjunctival Triamcinolone Acetonide Injection for the Treatment of Upper Eyelid Retraction in Patients With Thyroid Eye Disease
NCT07471997 is registered in ClinicalTrials.gov with Instituto de Oftalmología Fundación Conde de Valenciana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Transseptal and Transconjunctival Triamcinolone Acetonide Injection for the Treatment of Upper Eyelid Retraction in Patients With Thyroid Eye Disease
- Lead sponsor
- Instituto de Oftalmología Fundación Conde de Valenciana
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 20, 2024
- Completion date
- February 20, 2025
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
thyroid eye disease, ted